These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6395801)

  • 21. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
    Kita Y; Fugono T; Imada A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
    Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of carumonam in patients with renal insufficiency.
    Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
    Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and dose recommendations of carumonam in renal failure.
    Koeppe P; Höffler D; Strobel K
    Arzneimittelforschung; 1987 Jan; 37(1):65-9. PubMed ID: 3566860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro antibacterial activity of AMA-1080.
    Matsuda K; Hamana Y; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1985 Nov; 16(5):539-47. PubMed ID: 3878360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ertapenem in healthy young volunteers.
    Majumdar AK; Musson DG; Birk KL; Kitchen CJ; Holland S; McCrea J; Mistry G; Hesney M; Xi L; Li SX; Haesen R; Blum RA; Lins RL; Greenberg H; Waldman S; Deutsch P; Rogers JD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3506-11. PubMed ID: 12384357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
    Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saturable kinetics of intravenous chlorothiazide in the rhesus monkey.
    Gustafson JH; Benet LZ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):461-76. PubMed ID: 7310644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of probenecid on the pharmacokinetics of moxalactam.
    DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ; Le Van Thoi J; Duval JR
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
    Hohl P; von Graevenitz A; Zollinger-Iten J
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.